We aim to assess the spread of SARS-Covid2 infections by serological testing in our population of IBD-patients and describe its discourse in relation to patient characteristics, disease discourse and medication use
ID
Source
Brief title
Condition
- Gastrointestinal inflammatory conditions
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Serological status for SARS-Covid 2 at regular intervals defined by the moments
of routine blood sampling for the monitoring of disease activity and medication
use
Secondary outcome
Short survey concerning symptoms that may be related to a SARS-Covid2 infection
Background summary
The current SARS-Covid2 pandemic poses important questions related to the
treatment of patients with inflammatory bowel disease (IBD) As of jet we are
not able to answer these questions because the experience with SARS-Covid2
infections in IBD-patients is sparse and relies on case reports
Study objective
We aim to assess the spread of SARS-Covid2 infections by serological testing in
our population of IBD-patients and describe its discourse in relation to
patient characteristics, disease discourse and medication use
Study design
This will be an observational study that applies as invasive by sequential
extra blood sampling for SARS-Covid2 serological testing
Study burden and risks
participation in the study will imply the sampling of 1 extra bloodserum tube
(10 ml) at moments of blood sampling that are already indicated and scheduled
during routine patient care. In addition patients will be asked to fill in a
short 5 minutes survey on SARS-Covid2 related symptoms on these time points
Oosterpark 9
Amstredam 1091 AC
NL
Oosterpark 9
Amstredam 1091 AC
NL
Listed location countries
Age
Inclusion criteria
Adult (older than 18 y) patients with inflammatory bowel disease, under care in
OLVG, undergoing blood sampling for routine care
Exclusion criteria
Age below 18 years
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL73853.100.20 |